Related Experiment Videos
Adjuvant chemotherapy for colon cancer
1Division of Medical Oncology, Mayo Clinic Cancer Center, 200 First Street SW, Rochester, MN 55905, USA. goldberg.richard@mayo.edu
Current Oncology Reports
|March 20, 2001
Summary
Colon cancer is a leading cause of death, but earlier detection and improved therapies are decreasing mortality. Research continues to advance adjuvant chemotherapy for better colon cancer treatment outcomes.
Area of Science:
- Oncology
- Gastroenterology
Background:
- Colon cancer is a significant cause of cancer-related death in the US.
- Increased public awareness and screening have led to earlier detection and reduced mortality.
- Advances in understanding colon cancer's clinical behavior and molecular pathogenesis have improved therapies.
Purpose of the Study:
- To review the evolution and current status of adjuvant chemotherapy for colon cancer.
- To discuss recent advancements in colon cancer treatment strategies.
Main Methods:
- Review of large randomized trials over the last two decades.
- Analysis of multi-modality treatment strategies for colon cancer.
- Examination of the role of adjuvant therapy post-surgery.
Main Results:
- Adjuvant chemotherapy has become a cornerstone in colon cancer treatment post-surgery.
- Multi-modality treatment strategies have shown success in managing colon cancer.
- Despite progress, a significant number of patients still succumb to the disease.
Conclusions:
- Adjuvant chemotherapy plays a crucial role in the multi-modality treatment of colon cancer.
- Ongoing research is essential for developing more effective therapies to combat colon cancer.
- The field continues to evolve, seeking better outcomes for patients with colon cancer.